Discover the top stocks for the new year selected by Needham analysts, including ACV Auctions, Alcon, Alegro Microsystems, ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

By James Wagner and Luis Antonio Rojas CreditLuis Antonio Rojas for The New York Times. From the Surf to the Sermon: The Christian Surfers of Costa Rica A group of missionaries who surf have ...

If New Glenn lifts off on Monday as planned, the Amazon founder’s rocket company will be on track to give Elon Musk’s SpaceX some genuine competition. By Kenneth Chang As astrotourism booms ...